CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Laboratorios Andromaco S.A. (Parent) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Laboratorios Andromaco S.A. (Parent)
Av. Quilin 5273
Phone: +56 225948000p:+56 225948000 Penalolen, Chile Fax: +56 225948504f:+56 225948504

This is a Subsidiary, click here for the Parent Company

Business Summary
Laboratorios Andromaco SA is a Chile-based company primarily engaged, together with its subsidiaries, in the production, distribution and sale of a variety of pharmaceutical, cosmetic and diagnostic products, as well as clinic materials and veterinary drugs, among others. The Company's products portfolio comprises such brands as Abacten, Baxemin, Capent, Daivonex, Elcal, Flumed, Gabex, Histalen, Ibames, Kaion, Lactulosa, Micofin, Salbutamol, Clarimir, Dermaglos and Hipoglos, among others. Its facilities include two production plants intended for the production of hormonal and non-hormonal products, which are located in the Through its subsidiaries, the Company has operations established in Chile, Peru, Bolivia, Ecuador, Colombia, Panama, Costa Rica, El Salvador, the Dominican Republic, Guatemala and the British Virgin Islands. As of December 31, 2011, the Company’s major shareholder was Inversiones NM Limitada with 35% of its interest.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/200912/31/2009Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board Eric-PaulPaques 1/15/2014 1/15/2014
Chairman of the Board SergioWeinstein Aranda 1/15/2014
Chief Executive Officer OscarFerenczi 1/15/2014 1/15/2014
11 additional Officers and Directors records available in full report.

General Information
Number of Employees: 624 (As of 3/31/2007)
Outstanding Shares: 560,540,546 (As of 3/31/2014)
Fax Number: +56 225948504


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023